Treatment of patients with painful blind eye using stellate ganglion block

Xavier, Tatiana Vaz Horta; Oliveira, Thiago Robis de; Mendes, Tereza Cristina Bandeira Silva

doi:10.1016/j.bjane.2012.12.009

Cited by 8 publications

(6 citation statements)

References 12 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Several studies have attempted to address the management of pain, including a peribulbar injection of tramadol (analgesic), clonidine (anti-inflammatory), and ropivacaine (anesthetic) 35 or a cervicothoracic ganglion block with bupivacaine and clonidine. 36 Even after removal of the eye, it may not solve the issue of eye pain as persistent pain may develop as a result of neuromas 37 and phantom eye pain syndrome 38 . No clinical indication was documented in 23 cases (3%), and this points to the need for comprehensive documentation prior to organ removal.…”

Section: Discussionmentioning

confidence: 99%

A decade of surgical eye removals in Ontario: a clinical-pathological study

Chan

Khattak

Yucel

et al. 2017

Canadian Journal of Ophthalmology

View full text Add to dashboard Cite

A blind painful eye and neoplasms were the most commonly documented indications prior to removal of the eye. Common pathologies included glaucoma, neoplasms, infection/inflammation, and trauma. However, regardless of the primary cause, glaucoma-related pathologies were the most common pathologic findings. Refractory eye disease and pain continue to be important reasons for removal of eyes among patients in Ontario. More effective and targeted management strategies are needed to reduce the need for this radical eye surgery of last resort.

show abstract

Section: Discussionmentioning

confidence: 99%

A decade of surgical eye removals in Ontario: a clinical-pathological study

Chan

Khattak

Yucel

et al. 2017

Canadian Journal of Ophthalmology

View full text Add to dashboard Cite

show abstract

“…In addition, other indications are the novel syndrome known as “Long COVID” or Post‐Acute Sequelae of SARS‐CoV‐2 infection (PASC). Further controlled clinical trials are required to validate our findings 16–48 …”

Section: Discussionmentioning

confidence: 72%

Novel ultrasound‐guided supraclavicular stellate ganglion block

Fajardo Pérez,

Yamak‐Altinpulluk,

Díez Tafur

et al. 2024

Pain Practice

View full text Add to dashboard Cite

IntroductionStellate ganglion block (SGB) provides diagnostic and therapeutic benefits in pain syndromes in the head, neck, and upper extremity, including complex regional pain syndrome Types I and II, Raynaud's disease, hyperhidrosis, arterial embolism in the region of the arm.MethodsWe present a novel ultrasound‐guided supraclavicular stellate ganglion block. Considering the existing anatomical structures of the targeted area.Results and ConclusionsWe hope that we can provide fewer complications and additional benefits with this new approach.

show abstract

“…Full texts of the remaining 46 articles were assessed with 12 studies meeting eligibility criteria (Figure 1). Four retrospective cohort studies [28][29][30][31] , three case series [32][33][34] , and five case reports [35][36][37][38][39] were included.…”

Section: Search Resultsmentioning

confidence: 99%

“…Any individual or institution is free to copy, distribute, reproduce, or reuse these publications, as long as the author and original source are properly cited and credited. was deemed low in two studies 29,32 , moderate in one study 33 , and high in one study 34 (Table 10).…”

Section: Risk Of Biasmentioning

confidence: 99%

Interventional Management Of Neuropathic Ocular Pain – A Scoping Review

Hoydonckx

2024

AHM Journal

View full text Add to dashboard Cite

Neuropathic Ocular Pain (NOP) is a debilitating and refractory pain condition. This scoping review is the first to summarize the current evidence of efficacy of interventional treatment options for NOP. Databases were searched for studies published up to March 31, 2023. Two reviewers screened and extracted data, and performed the risk of bias analysis. Twelve studies were included, consisting of 4 cohort studies and 8 case series/reports, with a total of 87 patients. Eight interventions were defined: stellate ganglion block (n=1), trigeminal nerve blocks (n=3), retrobulbar block (n=1), pulsed radiofrequency of sphenopalatine ganglion (n=1), Onabotulinum-Toxin A(n=1), trigeminal nerve stimulation (n=1), intrathecal drug delivery (n=1) and transcutaneous electrical trigeminal nerve stimulation (n=3). Procedures were found to be safe and demonstrated analgesic effect. Follow-up ranged from 24h to 12 months. Substantial heterogeneity across studies was found, and quality was deemed low and of moderate risk of bias. High-quality studies are urgently needed.

show abstract

Treatment of patients with painful blind eye using stellate ganglion block

Cited by 8 publications

References 12 publications

A decade of surgical eye removals in Ontario: a clinical-pathological study

A decade of surgical eye removals in Ontario: a clinical-pathological study

Novel ultrasound‐guided supraclavicular stellate ganglion block

Interventional Management Of Neuropathic Ocular Pain – A Scoping Review

Contact Info

Product

Resources

About